Rutherford TomTOM RUTHERFORD (National—Bay of Plenty): Strap in. This is going to be a worthwhile contribution to wrap up the third reading of this bill. And the reason I say that is firstly this is my first contribution to the bill in the House but also to be following some of my colleagues particularly on this side who are esteemed in this field brings about some challenges for me.If I think about it just previously we had Dr Vanessa Weenink who gave us a very descriptive and incisive look into the detail of this bill and the work that happens in this space. Prior to her my colleague sitting next to me the MP for Mount Roskill Dr Carlos Cheung again another relevant and very very knowledgeable man in this space. And then oh I was listening diligently through all the contributions of this debate—this being the final and strap in. But prior to Dr Carlos Cheung was the MP for Ilam Dr Hamish Campbell again a specialist in his field really knows what he's talking about—Ingrid Leary: What about the women?TOM RUTHERFORD: What about the bill? Back in the corner well I didn't hear Dr Reti give a contribution to this debate so far but he's got a body of work that he's really working on. He's got a lot of priorities that he's focused on delivering and he's leaving it to the other doctors in our caucus to really take the charge with this bill and I appreciate what he's been doing in that space. So three previous speakers all doctors and now you get a Mr Rutherford rather than a doctor or anything.Dr Hamish Campbell: Mr or master?TOM RUTHERFORD: Yeah master my colleague says.But the National Party is really proud to support this bill led by the Hon David Seymour. We support it because the change of classification for pseudoephedrine as a controlled drug—this bill reclassifies it from a class B2 which it was changed to in 2011 to a class C3 controlled drug under the Misuse of Drugs Act 1975 so that cold and flu products containing pseudoephedrine can be sold in pharmacies without a prescription.That's quite a logical decision that this bill is bringing about change to. Patients are currently unable to access over-the-counter medicines containing pseudoephedrine medicines for the self-treatment of cold symptoms in New Zealand. Pseudoephedrine is an effective medicine. Allowing New Zealanders access to effective cold and flu medicine will help to improve peoples' welfare when they are unwell.We note Labour's support for the policy intent of this bill and we appreciate their support for it through the House. Tangi Utikere: Let's get on with it then.TOM RUTHERFORD: Let's get on with it". Oh colleagues across the House telling me to get on with it and rush. That's a change of tune—that's a change of tune from the other side. But I would say to them allowing New Zealanders access to this will improve peoples' welfare when they are unwell.I had a look through the regulatory impact statement that was prepared for the bill. You've got to be diligent when you stand to speak. I though "Aye let's have a look at access to pseudoephedrine in other jurisdictions." Australia prescription required? No. Canada prescription required? No. United Kingdom prescription required? No. What about the United States? No. So this is simply bringing New Zealand back into line with many other countries that we compare and contrast ourselves to across the world.Just to relay some of the comments made earlier in this debate relief is on the way for those New Zealanders who have battled through 14 winters without strong cold and flu medicine. Help is on the way and I commend this bill to the House.Motion agreed to.Bill read a third time."